Skip to main content

AGENDA

AGENDA

Fairmont Hotel Lake Louise

FRIDAY, MARCH 21, 2025

ALLIED HEALTH Professionals Program – Mt. Temple Ballroom
11:00 – 11:30h Lunch & Registration
11:30 – 15:35h ALLIED HEALTH Professionals Program
11:30 – 11:35h Opening Remarks – Ms. Nanette Cox-Kennett and Ms. Nikki Blosser
11:35 – 12:20h Adverse Effect Assessment and Management of CAR T and BiTE Therapy – Cameron Roessner , BSc. Pharm, PharmD
12:20 – 13:05h Compassion Fatigue – Jodi Collier RN BScN MN CON(C)
13:05 – 13:35h Geriatric Oncology: Considerations in LPD – Fay Strohschein, RN, PhD
13:35 – 13:45h Coffee Break
13:45 – 14:30h Navigating Difficult Conversations with Patients – Kyla Bailey (Pharmacist) and Sara Beattie Ph.D., R. Psych. Clinical Psychologist
14:30 – 15:30h Panel Discussion: Survivorship and Long Term Follow Up LPD – Nicole Crisp, Sara Beattie, Nikki Blosser & Nan Cox Kennett
15:30 – 15:35h Closing Remarks/ Evaluation Review – Ms. Nanette Cox-Kennett
1600 – 1700h Registration and Welcome Reception – Heritage Hall
1700 – 1710h Opening Remarks – Dr. Wendy Lam, Dr. Laurie Sehn – Mt. Temple Ballroom
CLL SESSION – Mt. Temple Ballroom
1710 – 1715h Welcome and Introductions –
1715 – 1740h Can We Use Genomics to Best Treat Our CLL Patients? – Dr. Jennifer Brown
1740 – 1800h Best Sequencing of Treatment Options for CLL – Dr. Versha Banerji
1800 – 1825h Battle of Front-line Time Limited Therapy for CLL

  • Why I+V is the Best Choice for Firstline Treatment of CLL Today – Dr. Carolyn Owen
  • Ven O – Dr. Versha Banerji
1825 – 1845h New Therapies for CLL – Dr. Jennifer Brown
1845 – 1920h Panel Discussion – Dr. Carolyn Owen, Dr. Jennifer Brown, Dr. Versha Banerji
1930h – Dinner

SATURDAY, MARCH 22, 2025

MYELOMA SESSION – Mt. Temple Ballroom
0630 – 0700h Breakfast
0700 – 0705h Welcome and Introductions –
0705 – 0725h Mechanisms of Resistance to T-cell Based Therapies in Myeloma – Dr. Paola Neri
0725 – 0745h Is ASCT Still Standard of Care in Myeloma for Eligible Patients? – Dr. Luciano Costa
0745 – 0805h Transplant Ineligible Myeloma: Quads for All? – Dr. Nizar Bahlis
0805 – 0825h Integrating Immune Effector Cell Therapies into Myeloma Algorithm – Dr. Luciano Costa
0825 – 0840h Management of Infectious Complications with Immune Effector Cell Therapies – Dr. Adil Adatia
0840 – 0905h Debate: Best Treatment for Triple Class Refractory Myeloma
CAR-T – Dr. Luciano Costa
Non CAR-T anti-BCMA – Dr. Nizar Bahlis
0905 – 1000h Panel Discussion – Dr. Paola Neri, Dr. Luciano Costa, Dr. Nizar Bahlis, Dr. Adil Adatia
1300 – 1645h Young Investigators’ Poster and Oral Presentations
1645 – 1700h Presentation Best Posters – Dr. Pam Skrabek
LYMPHOMA SESSION – Mt. Temple Ballroom
1700 – 1705h Welcome and Introductions –
1705 – 1730h Best of ASH – Dr. Nathalie Johnson
1730 – 1755h Playing the Long Game: Towards a Functional Cure of Follicular Lymphoma – Dr. Judith Trotman
1755 – 1820h Sequencing of Therapies for Relapsed Refractory Follicular Lymphoma – Dr. Gilles Salles
1820 – 1845h Optimizing Treatment in Patients with MCL – Dr. Matt Lunning
1845 – 1925h Panel Disussion – Dr. Nathalie Johnson, Dr. Judith Trotman, Dr. Gilles Salles, Dr. Matt Lunning
19:30h – Dinner

SUNDAY, MARCH 23, 2025

LYMPHOMA SESSION – Mt. Temple Ballroom
0630 – 0700h Breakfast
0700 – 0705h Welcome and Introductions –
0705 – 0730h Challenges and Progress in DLBCL – Dr. Gilles Salles
0730 – 0800h How Should We Tailor Treatment in Patients With PTCL – Dr. Matt Lunning
0800 – 0820h CART Therapy Selection for Older Lymphoma Patients – Dr. Anca Prica
0820 – 0850h Playing the Long Game in WM – Dr. Judith Trotman
0850 – 0955h Panel Discussion – Dr. Gilles Salles, Dr. Matt Lunning, Dr. Anca Prica, Dr. Judith Trotman
0955 – 1000h Closing Remarks – Dr. Laurie Sehn, Dr. Wendy Lam